Skip to main content
TECNOVAX S.A. logo

TECNOVAX S.A. — Investor Relations & Filings

ISIN · ARTNVX560020 BYMA Manufacturing
Open in API
Filings indexed 121 across all filing types
Latest filing 2024-04-05 Regulatory Filings
Country AR Argentina
Listing BYMA

About TECNOVAX S.A.

https://tecnovax.com/en/home-eng/

TECNOVAX S.A. is a biotechnology company dedicated to animal health, specializing in the research, development, and production of vaccines and immunotherapies. Leveraging its scientific expertise and decades of research, the company delivers safe and effective biological products for disease prevention. Its product portfolio targets a wide range of animals, including livestock such as ruminants and equines, aquatic species like salmonids, and companion animals including dogs and cats.

Recent filings

Filing Released Lang Actions
NORMA CONTABLE: NCP - TIPO BALANCE: INDIVIDUAL - PERIODICIDAD: SEMESTRAL - FECHA CIERRE: 2023-12-31 - ESTADOS CONTABLES - PYMES CNV, ADC, ACRYP Y CC
Regulatory Filings
2024-04-05 Spanish
FEC. CELEB.: 14-02-2024 - TEMA: EECC - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings
2024-04-04 Spanish
FEC. CELEB.: 26-03-2024 - TEMA: EMISIONES DE INSTRUMENTOS (ACCIONES - ON - VCP - FF) - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings
2024-03-26 Spanish
NORMA CONTABLE: NCP - TIPO BALANCE: INDIVIDUAL - PERIODICIDAD: SEMESTRAL - FECHA CIERRE: 2023-12-31 - ESTADOS CONTABLES - PYMES CNV, ADC, ACRYP Y CC
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial statements for a six-month period ending December 31, 2023, including balance sheets, income statements, cash flow statements, and notes. It also includes an independent auditor's review report specifically on interim financial statements, as well as a syndic's report. The presence of comparative financial data, auditor's review, and the six-month period clearly indicate this is an Interim / Quarterly Report. The document is substantive and contains actual financial data and analysis, not just an announcement or certification. Therefore, the appropriate classification is 'IR' for Interim / Quarterly Report.
2024-02-14 Spanish
FEC. CELEB.: 14-02-2024 - TEMA: EECC - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Board/Management Information Classification · 95% confidence The document is a meeting minute (Acta de Directorio) of the Board of Directors of Tecnovax S.A. held on February 14, 2024. The main agenda item was the approval of the financial statements for the six-month period ended December 31, 2023. The document records the approval of the financial statements by the board and authorization for the president to sign them. It does not contain the financial statements themselves or detailed financial data, but rather the board's resolution approving them. This type of document is a Board/Management Information filing, as it relates to board decisions and approvals rather than the full financial report or an announcement of report publication. The document length is short (1908 characters), and it is not an announcement of report availability but the record of board approval. Therefore, the correct classification is MANG (Board/Management Information).
2024-02-14 Spanish
FEC. CELEB.: 31-01-2024 - TEMA: EMISIONES DE INSTRUMENTOS (ACCIONES - ON - VCP - FF) - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings
2024-02-07 Spanish

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.